[{"Assets_0_Q2_USD":214663000.0,"CommonStockSharesOutstanding_0_Q2_shares":32063948.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":26108000.0,"NetIncomeLoss_2_Q2_USD":-45468000.0,"NetIncomeLoss_1_Q2_USD":-25541000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":3517000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":2575000.0,"StockholdersEquity_0_Q2_USD":81972000.0,"Ticker":"VYGR","CIK":"1640266","name":"VOYAGER THERAPEUTICS, INC.","OfficialName":"Voyager Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"363614047.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]